Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedRevision label on the page updated from v3.5.2 to v3.5.3. This represents a minor update to the page template and does not change the study details or data presented.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 in the page footer as part of a site update.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedPage revision history updated: v3.4.3 was removed and v3.5.0 was added.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.4.2 was added and the prior notice about government funding and operating status (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check93 days agoChange DetectedNotice added about a lapse in government funding and NIH Clinical Center status, with links to cc.nih.gov and opm.gov, and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.